Mental Health Pharma
322 million people worldwide live with depression. It is the most common form of mental illness. According to the National Institute of Mental Health (NIMH), 16.2 million, or 6.7 percent of total U.S. adults have had at least one major depressive episode in a given year.
Quality in Medication Matters
One of the primary concerns for the management of depression and overall mental health is the safety and effectiveness of prescribed antidepressants. Certification of medications may be the bridge between distrust in medication and medication non-adherence. Inferior expertise and bad manufacturing practices from the supply chain can lead to Poor-quality medications. The impact of low-quality medications can:
- Delay time to adequate treatment due to non-therapeutic drug levels
- Require frequent medication changes
- Increase the financial burden for patients, their families, and health systems.
According to the National Center for Health Statistics between the years 2002 – 2017, the use of antidepressant drugs rose from 7.7 percent to 65 percent. Antidepressant medications combined with psychological counseling are the gold standard for the treatment of depression.
Quality mental health medications are a key component of depression management. Tested and quality generics such as trazodone, quetiapine fumarate, paroxetine, sertraline hydrochloride, and citalopram are types of medication that can be effective for managing depression. Always consult with your doctor or psychiatrist and follow your medication instructions as prescribed.
Consistency in Medication
Depression may become a serious, chronic medical condition. Medication compliance not only increases the effectiveness of treatment but also reduces side effects, withdrawal symptoms, and relapse.
Evidence exists that quality of medications is strengthened by their efficacy. Prevention Research has shown that incorrect chemical composition of medication can alter expected outcomes and may result in adverse effects.
You are unique and a customized approach may be necessary. Because each of us has varying levels of neurotransmitter chemicals, a ‘one-size fits all’ approach is not effective. Consistency in medication is an important component in the treatment of depression and should be reflected in doses tailored to each individual patient.